Weis, N, et al.
Impact of hepatitis C virus coinfection on response to highly active antiretroviral therapy and outcome in HIV-infected individuals: a nationwide cohort study. Clinical Infectious Diseases
2006; 42: 1481–1487.
Omland, LH, et al.
Impact of hepatitis B virus co-infection on response to highly active antiretroviral treatment and outcome in HIV-infected individuals: a nationwide cohort study. HIV Medicine
2008; 9: 300–306.
Sabin, CA, et al.
The association between hepatitis C virus genotype and human immunodeficiency virus disease progression in a cohort of hemophilic men. Journal of Infectious Disease
1997; 175: 164–168.
Sulkowski, MS, et al.
Hepatitis C and progression of HIV disease. Journal of the American Medical Association
2002; 288: 199–206.
Hoffmann, CJ, et al.
Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART program. Clinical Infectious Diseases
2008; 47: 1479–1485.
Riley, ED, et al.
Antiretroviral therapy, hepatitis C virus, and AIDS mortality among San Francisco's homeless and marginally housed. Journal of Acquired Immune Deficiency Syndrome
2005; 38: 191–195.
Macías, J, et al.
Influence of hepatitis C virus infection on the mortality of antiretroviral-treated patients with HIV disease. European Journal of Clinical Microbiology and Infectious Diseases
1998; 17: 167–170.
Sherman, KE, et al.
Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clinical Infectious Diseases. 2002; 34: 831–837.
Sulkowski, MS, Thomas, DL. Hepatitis C in the HIV-infected person. Annals of Internal Medicine
2003; 138: 197–207.
Thomas, DL. Hepatitis C and human immunodeficiency virus infection. Hepatology
2002; 36: 201–209.
Thio, CL, et al.
HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet
2002; 360: 1921–1926.
Bonacini, M, et al.
Survival in patients with HIV infection and viral hepatitis B or C: a cohort study. AIDS
2004; 18: 2039–2045.
Konopnicki, D, et al.
Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS
2005; 19: 593–601.
Ockenga, J, et al.
Hepatitis B and C in HIV-infected patients. Prevalence and prognostic value. Journal of Hepatology
1997; 27: 18–24.
Greub, G, et al.
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet
2000; 356: 1800–1805.
Voirin, N, et al.
Survival in HIV-infected patients is associated with hepatitis C virus infection and injecting drug use since the use of highly active antiretroviral therapy in the Lyon observational database. Journal of Viral Hepatitis
2004; 11: 559–562.
Sheng, WH, et al.
Impact of chronic hepatitis B virus (HBV) infection on outcomes of patients infected with HIV in an area where HBV infection is hyperendemic. Clinical Infectious Diseases
2004; 38: 1471–1477.
Anderson, KB, Guest, JL, Rimland, D. Hepatitis C virus coinfection increases mortality in HIV-infected patients in the highly active antiretroviral therapy era: data from the HIV Atlanta VA Cohort Study. Clinical Infectious Diseases
2004; 39: 1507–1513.
Backus, LI, et al.
Effects of hepatitis C virus coinfection on survival in veterans with HIV treated with highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndrome
2005; 39: 613–619.
Marcellin, P, et al.
Mortality related to chronic hepatitis B and chronic hepatitis C in France: evidence for the role of HIV coinfection and alcohol consumption. Journal of Hepatology
2008; 48: 200–207.
Hoffmann, CJ, et al.
Hepatitis B and long-term HIV outcomes in coinfected HAART recipients. AIDS
2009; 23: 1881–1889.
Nikolopoulos, GK, et al.
Impact of hepatitis B virus infection on the progression of AIDS and mortality in HIV-infected individuals: a cohort study and meta-analysis. Clinical Infectious Diseases
2009; 48: 1763–1771.
Chen, TY, et al.
Meta-analysis: increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression. Clinical Infectious Diseases
2009; 49: 1605–1615.
Butt, ZA, et al.
Hepatitis B and C co-infection in HIV/AIDS population in the state of Michigan. Epidemiology and Infection. Published online:
. doi: 10.1017/S0950268813000538.
Kim, JH, et al.
Co-infection of hepatitis B and hepatitis C virus in human immunodeficiency virus-infected patients in New York City, United States. World Journal of Gastroenterology
2008; 14: 6689–6693.
Anon. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbidity and Mortality Weekly Report. Recommendations and Report
1992; 41: 1–19.
Hansen, AB, et al.
Mortality in siblings of patients coinfected with HIV and hepatitis C virus. Journal of Infectious Diseases
2007; 195: 230–235.
Hansen, AB, et al.
Cause-specific excess mortality in siblings of patients co-infected with HIV and hepatitis C virus. PLoS One
2007; 2: e738.
Marins, JR, et al.
Characteristics and survival of AIDS patients with hepatitis C: the Brazilian National Cohort of 1995–1996. AIDS
2005; 19: 27–30.
Jain, MK. Mortality in patients coinfected with hepatitis B virus and HIV: could antiretroviral therapy make a difference?
Clinical Infectious Diseases
2009; 48: 1772–1774.
Emery, J, et al.
Gender differences in clinical, immunological, and virological outcomes in highly active antiretroviral-treated HIV-HCV coinfected patients. Patient Preference and Adherence
2010; 4: 97–103.
Rozenberg, L, et al.
Therapeutic response to peg-IFN-alpha-2b and ribavirin in HIV/HCV co-infected African-American and Caucasian patients as a function of HCV viral kinetics and interferon pharmacodynamics. AIDS
2009; 23: 2439–2450.
Rosenthal, E, et al.
Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study). AIDS
2003; 17: 1803–1809.
Tedaldi, EM, et al.
Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy. Clinical Infectious Diseases
2003; 36: 363–367.